RXG

Pharmacy/Treatment Give

Figure 4-18. RXG attributes
22
C.LenElementv2.3
1..4-NMR1-00342RXG-1Give Sub-ID Counter2
2..4-NMO1-00334RXG-2Dispense Sub-ID CounterOptionality
3..200-TQR1-00221RXG-3Quantity/Timing
4..100-CE_0292R1029200317RXG-4Give Code2
5..20-NMR1-00318RXG-5Give Amount - Minimum
6..20-NMO1-00319RXG-6Give Amount - Maximum
7..60-CER1-00320RXG-7Give Units
8..60-CEO1-00321RXG-8Give Dosage Form
9..200-CEO*-00351RXG-9Administration NotesOptionality
10..1-IDO1016700322RXG-10Substitution Status
11..200-LA2O1-01303RXG-11Dispense-To LocationData Type
12..1-IDO1013600307RXG-12Needs Human Review
13..200-CEO*-00343RXG-13Pharmacy/Treatment Supplier’s Special Administration Instructions3
14..20-STC1-00331RXG-14Give Per (Time Unit)
15..6-STO1-00332RXG-15Give Rate Amount
16..60-CEO1-00333RXG-16Give Rate Units
17..20-NMO1-01126RXG-17Give Strength
18..60-CEO1-01127RXG-18Give Strength Units
19..20-STO*-01129RXG-19Substance Lot Number
20..26-TSO*-01130RXG-20Substance Expiration Date
21..60-CE_0227O*022701131RXG-21Substance Manufacturer NameData Type
22..200-CEO*-01123RXG-22IndicationRepetition
2